Internal exposure-based pharmacokinetic evaluation of potential for biopersistence of 6:2 fluorotelomer alcohol (FTOH) and its metabolites
- 1 February 2018
- journal article
- research article
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 112, 375-382
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- 8:2 fluorotelomer alcohol: A one-day nose-only inhalation toxicokinetic study in the Sprague-Dawley rat with application to risk assessmentToxicology, 2012
- Absorption, distribution, metabolism, and excretion of [1-14C]-perfluorohexanoate ([14C]-PFHx) in rats and miceToxicology, 2011
- Human Organic Anion Transporter hOAT4 is a Transporter of Perfluorooctanoic AcidBasic & Clinical Pharmacology & Toxicology, 2009
- A 90-day repeated dose oral (gavage) toxicity study of perfluorohexanoic acid (PFHxA) in rats (with functional observational battery and motor activity determinations)Reproductive Toxicology, 2009
- Bioactivation of fluorotelomer alcohols in isolated rat hepatocytesChemico-Biological Interactions, 2009
- 90-Day Oral Gavage Toxicity Study of 8-2 Fluorotelomer Alcohol in RatsDrug and Chemical Toxicology, 2008
- In Vitro Metabolism of 8-2 Fluorotelomer Alcohol: Interspecies Comparisons and Metabolic Pathway RefinementToxicological Sciences, 2007
- Allometric scaling of xenobiotic clearance: Uncertainty versus universalityAAPS PharmSci, 2001
- Man versus Beast: Pharmacokinetic Scaling in MammalsJournal of Pharmaceutical Sciences, 1986
- Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1982